CDC will not discharge Hurricane Katrina response report CDC will use a report analyzing the agency’s response to Hurricane Katrina to boost emergency preparedness but will not make information on the report open public, according to company officials, the Atlanta Journal-Constitution reports addyi . CDC dispatched 700 workers during the wake of the hurricane to handle disease prevention and monitoring, care for displaced residents and offer them with vaccinations. The agency acknowledges it was not prepared to fully implement federal command structures and regular operating procedures as necessary by the National Response Program.
CGEN-671, a new drug target for multiple epithelial tumors discovered by Compugen Compugen Ltd. announced today the discovery and experimental validation of CGEN-671, a new drug target for multiple epithelial tumors. CGEN-671 is certainly a membrane splice variant of CD55, a known drug target for gastric cancer for which monoclonal antibody therapeutics are in clinical advancement by others. The potential application of CGEN-671 as a drug target was predicted in initially silico by Compugen through the use of its Monoclonal Antibody Targets Discovery Platform; the predicted molecule was validated experimentally in multiple epithelial tumors. Epithelial tumors, also known as carcinomas, take into account approximately 85 percent of most cancers, including the ten most prevalent cancers in the western world, such as breasts, colorectal, lung, ovary, prostate and skin.